Physiological Effect: Decreased Cell Membrane Integrity
✉ Email this page to a colleague
Drugs with Physiological Effect: Decreased Cell Membrane Integrity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 9,522,155 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 10,500,214 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,546,367 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,461,140 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 7,754,230 | ⤷ Subscribe | ⤷ Subscribe | |||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,653,058 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Abbvie | KYBELLA | deoxycholic acid | SOLUTION;SUBCUTANEOUS | 206333-001 | Apr 29, 2015 | AP | RX | Yes | Yes | 8,846,066 | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
